Scanogen Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $818K

  • Investors
  • 7

Scanogen General Information

Description

Operator of a molecular diagnostic company intended to develop amplification-free molecular detection. The company has developed Single Molecule Tethering (SMOLT) proprietary technology for rapid and ultra-sensitive detection of biomolecules, developing a simple-to-use and sample-to-answer diagnostic platform, enabling clinicians with easy access to the biomolecular information of body fluids to improve healthcare.

Contact Information

Formerly Known As
Twistnostics
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Biotechnology
Corporate Office
  • 3102 Lord Baltimore Drive
  • Suite 214
  • Baltimore, MD 21244
  • United States
+1 (410) 000-0000

Scanogen Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Scanogen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Grant 30-Jan-2023 $818K Completed Generating Revenue
7. Grant 19-Apr-2022 00.00 Completed Generating Revenue
6. Grant 07-Feb-2020 00.000 Completed Generating Revenue
5. Grant 13-Feb-2017 00.000 Completed Generating Revenue
4. Grant 01-Jan-2017 00.000 Completed Generating Revenue
3. Grant 01-Jun-2016 00000 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Grant 19-Sep-2013 $153K Completed Generating Revenue
To view Scanogen’s complete valuation and funding history, request access »

Scanogen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a molecular diagnostic company intended to develop amplification-free molecular detection. The company has d
Diagnostic Equipment
Baltimore, MD
10 As of 2023
0000000000

00 000

enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip
0000000000 000000000
Lexington, MA
000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Scanogen Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
T2 Biosystems Formerly VC-backed Lexington, MA 000 00000 00000000 00000
You’re viewing 1 of 1 competitors. Get the full list »

Scanogen Patents

Scanogen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220291212-A1 Detection units and methods for detecting a target analyte Pending 25-May-2018 000000000000
US-11371986-B2 Detection units and methods for detecting a target analyte Active 25-May-2018 000000000000 0
US-20190361016-A1 Detection units and methods for detecting a target analyte Active 25-May-2018 000000000000
US-20190040344-A1 Device and method for sample analysis Inactive 27-Jul-2017 000000000
US-11360296-B2 Imaging system Active 20-Jun-2016 G02B21/365 00
To view Scanogen’s complete patent history, request access »

Scanogen Executive Team (1)

Name Title Board Seat Contact Info
Alfredo Celedon Ph.D Founder & Chief Executive Officer
To view Scanogen’s complete executive team members history, request access »

Scanogen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Scanogen Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institute for Allergy and Infectious Disease Government 000 0000 000000 0
The National Institute on Aging (NIA) Government 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
National Cancer Institute Government 000 0000 000000 0
The National Human Genome Research Institute Government 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Scanogen FAQs

  • When was Scanogen founded?

    Scanogen was founded in 2011.

  • Who is the founder of Scanogen?

    Alfredo Celedon Ph.D is the founder of Scanogen.

  • Who is the CEO of Scanogen?

    Alfredo Celedon Ph.D is the CEO of Scanogen.

  • Where is Scanogen headquartered?

    Scanogen is headquartered in Baltimore, MD.

  • What is the size of Scanogen?

    Scanogen has 10 total employees.

  • What industry is Scanogen in?

    Scanogen’s primary industry is Diagnostic Equipment.

  • Is Scanogen a private or public company?

    Scanogen is a Private company.

  • What is Scanogen’s current revenue?

    The current revenue for Scanogen is 00000.

  • Who are Scanogen’s investors?

    National Institute for Allergy and Infectious Disease, The National Institute on Aging (NIA), National Institutes of Health, National Cancer Institute, and The National Human Genome Research Institute are 5 of 7 investors who have invested in Scanogen.

  • Who are Scanogen’s competitors?

    T2 Biosystems is a competitor of Scanogen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »